2011年10月11日星期二

Vitamin E tied to higher risk of prostate cancer

AppId is over the quota
AppId is over the quota
By Genevra Pittman

NEW YORK | Tue Oct 11, 2011 5:21pm EDT

NEW YORK (Reuters Health) - Men taking daily vitamin E were more likely to get prostate cancer than those not taking the dietary supplement in a new study of close to 35,000 North Americans.

Over a decade, an additional one or two men out of 100 taking vitamin E would be expected to get prostate cancer, researchers found.

"If you have enough of these vitamins in your system... extra doesn't help you any, and too much of something like this can be harmful," Dr. Eric Klein from the Cleveland Clinic, one of the study's authors, told Reuters Health.

The findings, released today in the Journal of the American Medical Association, come on the heels of a study suggesting older women who take multivitamins have slightly increased death rates than those who don't (see Reuters Health story of October 10, 2011).

"There's a theme here that taking vitamins is not only not helpful but could be harmful" in people who aren't deficient, Klein said.

Still, one researcher who wasn't part of the new study said he doubts it means vitamin E causes prostate cancer.

According to the National Cancer Institute, about 241,000 men in the U.S. will be diagnosed with prostate cancer in 2011, and close to 34,000 will die from the disease.

Although men are typically screened regularly for prostate cancer with prostate-specific antigen (PSA) tests, a government-funded task force recently put out draft recommendations saying that the screening doesn't prevent men from dying of cancer, but may cause undue harm through unnecessary procedures.

For the current study, men in the U.S., Canada and Puerto Rico were randomly assigned to one of four groups. Starting between 2001 and 2004, about 9,000 men each took daily supplements of 400 international units (IU) of vitamin E, 200 micrograms of selenium, vitamin E and selenium together or a vitamin-free placebo pill.

The study was halted in late 2008 when the researchers saw a hint of an increased risk of prostate cancer in men taking vitamin E, but they kept monitoring men for cancer after they stopped taking the supplements. And it turned out that extra risk became clearer over time.

By mid-2011, about seven percent of men who had taken vitamin E only had gotten prostate cancer, compared to six percent of those assigned to the placebo pills.

The researchers didn't find an extra risk of prostate cancer in men who took only selenium or vitamin E together with selenium.

Klein and his colleagues say it's not clear how vitamin E would increase the risk of prostate cancer, and that not all past studies have shown it does any harm to the prostate. Some have even found a lower prostate-cancer risk with vitamin E.

He said the new findings aren't definite proof that vitamin E causes extra prostate cancers, but that there wasn't anything else that could explain why men taking the vitamin were more likely to be diagnosed with cancer -- for example, they weren't screened more frequently.

The supplement doses, he added, are much higher than what's in most over-the-counter multivitamins, which typically contain 15 to 25 IU of vitamin E.

Prostate cancer researcher Dr. Neil Fleshner, from the University of Toronto, was doubtful that vitamin E does in fact increase the risk of prostate cancer, and said the result may have been a chance finding, or a "false positive."

"It's an interesting finding. I'm not sure I believe it," he told Reuters Health. Either way, he said, vitamin E doesn't seem to be beneficial for prostate health.

"There's certainly no major evidence that vitamin E helps," he said. "So, why bother?"

Vitamin supplements are known to prevent disease in people who have vitamin deficiencies, Klein said, but so far studies generally haven't found much extra benefit in people who already get enough vitamins through their diet. Specifically, vitamin E has not been shown to protect against heart disease, colon cancer or lung cancer.

On the other hand, there is a growing body of evidence suggesting supplements may be harmful in high doses.

"Vitamins are not innocuous substances," Klein concluded.

SOURCE: bit.ly/rnslfz Journal of the American Medical Association, online October 11, 2011.


View the original article here

Chocolate lovers have fewer strokes, study finds

AppId is over the quota
AppId is over the quota
Chocolates made by Belgian Christine Scholtes Covic are displayed in her Lika Chocolate workshop in the village of Rakovica, in the Croatian region of Lika, some 150 kilometres (93 miles) south of Zagreb January 21, 2011. REUTERS/Nikola Solic

Chocolates made by Belgian Christine Scholtes Covic are displayed in her Lika Chocolate workshop in the village of Rakovica, in the Croatian region of Lika, some 150 kilometres (93 miles) south of Zagreb January 21, 2011.

Credit: Reuters/Nikola Solic

By Frederik Joelving

NEW YORK | Mon Oct 10, 2011 5:39pm EDT

NEW YORK (Reuters Health) - A sweet tooth isn't necessarily bad for your health-- at least not when it comes to chocolate, hints a new study.

Researchers studying more than 33,000 Swedish women found that the more chocolate women said they ate, the lower their risk of stroke.

The results add to a growing body of evidence linking cocoa consumption to heart health, but they aren't a free pass to gorge on chocolate.

"Given the observational design of the study, findings from this study cannot prove that it's chocolate that lowers the risk of stroke," Susanna Larsson from Karolinska Institutet in Stockholm told Reuters Health in an email.

While she believes chocolate has health benefits, she also warned that eating too much of it could be counterproductive.

"Chocolate should be consumed in moderation as it is high in calories, fat, and sugar," she said. "As dark chocolate contains more cocoa and less sugar than milk chocolate, consumption of dark chocolate would be more beneficial."

Larsson and her colleagues, whose findings appear in the Journal of the American College of Cardiology, tapped into data from a mammography study that included self-reports of how much chocolate women ate in 1997. The women ranged in age from 49 to 83 years.

Over the next decade, there were 1,549 strokes, and the more chocolate women ate, the lower their risk.

Among those with the highest weekly chocolate intake -- more than 45 grams -- there were 2.5 strokes per 1,000 women per year. That figure was 7.8 per 1,000 among women who ate the least (less than 8.9 grams per week).

Scientists speculate that substances known as flavonoids, in particular so-called flavanols, may be responsible for chocolate's apparent effects on health.

According to Larsson, flavonoids have been shown to cut high blood pressure, a risk factor for stroke, and improve other blood factors linked to heart health. Whether that theoretical benefit translates into real-life benefits remains to be proven by rigorous studies, however.

Nearly 800,000 Americans suffer a stroke every year, with about a sixth of them dying of it and many more left disabled. For those at high risk, doctors recommend blood pressure medicine, quitting smoking, exercising more and eating a healthier diet -- but so far chocolate isn't on the list.

SOURCE: bit.ly/qhsaZ0 Journal of the American College of Cardiology, October 10, 2011.


View the original article here

UPDATE 1-Scania to cut Europe production on economic woes

AppId is over the quota
AppId is over the quota

(Adds background, details from statement)

* Says to lower production 10 to 15 pct from Nov in Europe

* Says slowing economic activity in Europe, US affecting customers

* Says demand in Latin America stable at high level

* Shares down 4 pct

STOCKHOLM, OCT 10 - Swedish truck maker Scania (SCVb.ST) said on Monday it would cut its production rate in Europe from November due to weaker demand, knocking its share price lower.

"It is a matter of deceleration in Europe, but also a slower pace of order bookings from the Middle East," said Martin Lundstedt, Executive Vice President in charge of Scania's sales and marketing.

Scania said government financial problems in Europe and the US had begun to affect economic activity and led to hesitation among customers. It plans to cut production in Europe by 10 to 15 percent from November compared with the end of the third quarter.

The company, however, said demand in Latin America had stabilised at a high level.

Shares in Scania were down 4.7 percent at 1012 GMT compared to a 0.6 percent rise in the wider Stockholm bourse. .

Scania, majority-owned by German auto maker Volkswagen (VOWG_p.DE), said in late August its view of the market had not changed from July.

(Editing by Helen Massy-Beresford)


View the original article here

D'Ieteren , VW set up Belgian vehicle finance j/v

AppId is over the quota
AppId is over the quota

BRUSSELS | Mon Oct 10, 2011 3:43am EDT

BRUSSELS Oct 10 (Reuters) - Belgian car distributor D'Ieteren said on Monday it and Volkswagen Financial Services would set up a joint venture to finance Volkswagen vehicles in Belgium.

D'Ieteren distributes Volkswagen's (VOWG_p.DE) range in Belgium.

The joint venture, VDFin, should be operational from Jan 1, 2012, with financial services for private individuals, professionals and dealers, D'Ieteren said in a statement.

VDFin will combine D'Ieteren Lease and the operations of Volkswagen Bank Belgium. The agreement is subject to approval by the competition authorities. (Writing by Rex Merrifield)


View the original article here

UPDATE 2-Konecranes cuts forecast after Q3 disappoints

AppId is over the quota
AppId is over the quota

* Says 2011 core EBIT to be flat vs 2010

* Says services unit performance to miss expectations

* Shares fall some 4 pct (Adds analyst quotes, share reaction)

HELSINKI, Oct 10 (Reuters) - Finnish crane maker Konecranes cut its full-year profit forecast on Monday after reporting a weaker than expected third quarter performance in services.

Shares fell 4.0 percent to 14.69 euros in early trade. The stock has lost about 50 percent since early July.

The company said it now expects its 2011 core operating profit to reach the same level as last year, having previously predicted a rise.

Konecranes said its preliminary third-quarter order intake was about 459 million euros ($619 million), sales were 451 million and operating profit reached 26 million euros.

It also said its service segment profitability will fall short of expectations this year.

"Growth in deliveries has been slower than originally planned, which affects fixed cost absorption in the expanded service network. Growth in capacity utilization within key customer groups has stagnated, affecting spare parts demand and thus our profitability," it said in a statement.

Konecranes invested in growth and hired more services staff in the first half of the year.

"It was surprising that these problems occurred so soon, one could have imagined that 2012 is when slowdown begins to appear," said Ohman analyst Jari Harjunpaa.

Analysts said the markets were interested in hearing what action the firm would take to boost services profitability and what kind of uncertainties it saw.

In 2010 Konecranes reported 115 million euros of operating profit excluding restructuring costs, on sales of 1.5 billion euros.

Konecranes publishes third quarter earnings on October 20. ($1 = 0.741 euros) (Reporting by Terhi Kinnunen and Jussi Rosendahl; Editing by Greg Mahlich and Helen Massy-Beresford)


View the original article here

India Sept car sales fall 1.8 pct y/y - industry body

AppId is over the quota
AppId is over the quota

NEW DELHI | Mon Oct 10, 2011 4:19am EDT

NEW DELHI Oct 10 (Reuters) - Car sales in India fell 1.8 percent in September, an industry body said on Monday, as rising interest rates and vehicle costs hurt demand in the world's second-fastest growing auto market after China.

Indian automakers sold 165,925 cars in September, according to data released by the Society of Indian Automobile Manufacturers (SIAM).

Sales of trucks and buses, a key pointer to the country's economic activity, rose 18.05 percent to 70,634 in September, SIAM said.

Demand for cars had shrank in July for the first time in nearly three years. (Reporting by Sanjeev Choudhary; Editing by Ranjit Gangadharan)


View the original article here

Renault to announce strengthened CEO role Friday-report

AppId is over the quota
AppId is over the quota

PARIS | Mon Oct 10, 2011 4:16am EDT

PARIS Oct 10 (Reuters) - Auto maker Renault is expected to announce a board reorganisation on Friday that will widen the responsibilities of Chief Executive Carlos Ghosn, French daily La Tribune reported without citing sources.

Ghosn, who is also chief executive of Renault's Japanese alliance partner Nissan Motor , is expected to take on additional duties, such as internal audit and risk management, in a move to show the French car maker has become his main priority, the newspaper said.

Earlier this year Renault fired several executives based on suspicions of industrial espionage that later proved unfounded.

At that time, Ghosn came under fire for his handling of the scandal, which some critics said exposed weak risk controls at the car maker.

Renault was not immediately available to comment. (Reporting By Elena Berton; Editing by Helen Massy-Beresford)


View the original article here